CSIR-NIIST introduces new tech for biomedical waste safety
WATER & WASTE

CSIR-NIIST introduces new tech for biomedical waste safety

The CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) had introduced a pioneering technology aimed at the safe, sustainable, and cost-effective management of biomedical waste, representing a significant milestone as the first of its kind in the country.

This groundbreaking technology had been unveiled during the Biomedical Waste Management Conclave, a one-day event held at the CSIR-NIIST campus in the city on March 26.

As reported by UNI, Dr M Srinivas, Director of AIIMS New Delhi, had inaugurated the event, which had been presided over by Dr N Kalaiselvi, Secretary of DSIR and Director General of CSIR, via videoconferencing.

Dr Srinivas had stressed the importance of innovative technologies in the biomedical sector and had reiterated AIIMS' commitment to collaborating with academic and research institutions, particularly CSIR. He had praised CSIR-NIIST Director Dr C Anandharamakrishnan and his team for their innovative solution for the disposal of pathogenic biomedical waste.

Dr Kalaiselvi had remarked that the biomedical waste treatment technology developed by CSIR-NIIST would effectively tackle one of the major challenges of modern times. She had noted, "This technology will significantly impact the global biomedical arena by addressing the limitations of conventional technologies, including energy-intensive incineration."

Dr Anandharamakrishnan had explained that with the technology, one kilogram of medical waste could be converted into soil additives in three minutes, suitable for agricultural purposes. As per the UNI news agency, he had mentioned that this safe and cost-effective technology would facilitate hospitals in disposing of medical waste easily at its source.

However, the implementation of this technology in hospitals nationwide necessitated approval from the Central Pollution Control Board.

"CSIR-NIIST is actively exploring various waste management strategies, including biomedical waste. The technology we developed for converting pathogenic biomedical waste into value-added soil additives serves as a perfect example of the 'Waste to Wealth' concept," he had added.

Following the development of this groundbreaking technology, CSIR-NIIST had transferred it to Bio Vastum Solutions, a firm based in Angamaly.

The CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) had introduced a pioneering technology aimed at the safe, sustainable, and cost-effective management of biomedical waste, representing a significant milestone as the first of its kind in the country. This groundbreaking technology had been unveiled during the Biomedical Waste Management Conclave, a one-day event held at the CSIR-NIIST campus in the city on March 26. As reported by UNI, Dr M Srinivas, Director of AIIMS New Delhi, had inaugurated the event, which had been presided over by Dr N Kalaiselvi, Secretary of DSIR and Director General of CSIR, via videoconferencing. Dr Srinivas had stressed the importance of innovative technologies in the biomedical sector and had reiterated AIIMS' commitment to collaborating with academic and research institutions, particularly CSIR. He had praised CSIR-NIIST Director Dr C Anandharamakrishnan and his team for their innovative solution for the disposal of pathogenic biomedical waste. Dr Kalaiselvi had remarked that the biomedical waste treatment technology developed by CSIR-NIIST would effectively tackle one of the major challenges of modern times. She had noted, This technology will significantly impact the global biomedical arena by addressing the limitations of conventional technologies, including energy-intensive incineration. Dr Anandharamakrishnan had explained that with the technology, one kilogram of medical waste could be converted into soil additives in three minutes, suitable for agricultural purposes. As per the UNI news agency, he had mentioned that this safe and cost-effective technology would facilitate hospitals in disposing of medical waste easily at its source. However, the implementation of this technology in hospitals nationwide necessitated approval from the Central Pollution Control Board. CSIR-NIIST is actively exploring various waste management strategies, including biomedical waste. The technology we developed for converting pathogenic biomedical waste into value-added soil additives serves as a perfect example of the 'Waste to Wealth' concept, he had added. Following the development of this groundbreaking technology, CSIR-NIIST had transferred it to Bio Vastum Solutions, a firm based in Angamaly.

Next Story
Infrastructure Urban

Reliance, Diehl Advance Pact for Precision-Guided Munitions

Diehl Defence CEO Helmut Rauch and Reliance Group’s Founder Chairman Anil D. Ambani have held discussions to advance their ongoing strategic partnership focused on Guided and Terminally Guided Munitions (TGM), under a cooperation agreement originally signed in 2019.This collaboration underscores Diehl Defence’s long-term commitment to the Indian market and its support for the Indian Government’s Make in India initiative. The partnership’s current emphasis is on the urgent supply of the Vulcano 155mm Precision Guided Munition system to the Indian Armed Forces.Simultaneously, the “Vulc..

Next Story
Infrastructure Urban

Modis Navnirman to Migrate to Main Board, Merge Subsidiary

Modis Navnirman Limited has announced that its Board of Directors has approved a key strategic initiative involving migration from the BSE SME platform to the Main Board of both BSE and NSE, alongside a merger with its wholly owned subsidiary, Shree Modis Navnirman Private Limited.The move to the main boards marks a major milestone in the company’s growth trajectory, reflecting its consistent financial performance, robust corporate governance, and long-term commitment to value creation. This transition will grant the company access to a broader investor base, improve market participation, en..

Next Story
Infrastructure Urban

Global Capital Flows Remain Subdued, EMEA Leads in Q1 2025

The Bharat InvITs Association’s industry update for Q1 2025 shows subdued global capital flows, with investment volumes remaining at the lower end of the five-year range despite a late 2024 recovery. According to data from Colliers and MSCI Real Capital Analytics, activity in North America declined slightly, while EMEA maintained steady levels and emerged as the top region for investment in standing assets.The EMEA region now hosts seven of the top ten cross-border capital destinations for standing assets, pushing the United States’ share of global activity below 15 per cent. Meanwhile, in..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?